One study by Carola Torazza and her team at the University of Genoa has shed light on a promising avenue for treating Amyotrophic Lateral Sclerosis (ALS) by targeting a specific receptor in , known as metabotropic glutamate receptor type 5 (mGluR5). Published on July 27, 2023, in the journal …
A study by Aradhana Sachdev and colleagues, published on April 23, 2024, in the Proceedings of the National Academy of Sciences of the United States of America, sheds light on potential genetic interventions for conditions linked to the C9orf72 , a major contributor to amyotrophic lateral sclerosis (ALS) …
A study by Shravan Gowrishankar and colleagues, published in PloS One in 2024, has provided valuable insights into the use of immunosuppression in stem clinical trials, particularly for conditions like amyotrophic lateral sclerosis (ALS). Conducted by researchers from the Department of ENT at Cambridge University Hospitals in the United …
One study by Ton Fang and colleagues from King's College London has provided valuable insights into how the medication riluzole affects survival in patients with amyotrophic lateral sclerosis (ALS). Published in The Lancet Neurology in May 2018, this research analyzed data from a previous clinical trial to determine at which …
A study by Francis R. Willett and colleagues, published in August 2023 in the journal Nature, explores a groundbreaking speech neuroprosthesis that could significantly enhance communication for individuals with amyotrophic lateral sclerosis (ALS) and other conditions that impair speech. Conducted at the Howard Hughes Medical Institute at Stanford University, …
One study published in JAMA Neurology has found a potential connection between dietary intake of omega-3 polyunsaturated fatty acids (PUFAs) and a reduced risk of developing amyotrophic lateral sclerosis (ALS). The research, led by Kathryn C. Fitzgerald and colleagues from the Department of Nutrition at Harvard School of Public Health, …